The NHS is rapidly enrolling patients into studies as part of a focused international effort to find medicines that will interfere with viral replication or help modulate the immune system response.
There is a vulnerable group we must not leave behind in our response to COVID-19: people who are dependent on illicit drugs
None of us are safe from COVID-19, but the health status, needs and behaviours of those who use illicit drugs leave them particularly vulnerable — pharmacists can reduce this risk, says drugs researcher Amira Guirguis.
The chief executive officer of the Association of Independent Multiple Pharmacies speaks about how the coronavirus pandemic has affected pharmacy and the risk of impending closures.
How pharmacists can ensure the safe delivery of chimeric antigen receptor T-cell therapy by ensuring governance, operational and clinical requirements are met.
The COVID-19 pandemic has highlighted the importance of understanding the differences between viral and bacterial pneumonia, and how adult patients can be managed as they recover at home.
Case-based learning: anxiety disordersSubscription
There are many types of anxiety disorders with varying levels of severity. Pharmacists should know the treatment options that are available and how to support patients.
Evaluation of the impact of pharmacist polypharmacy reviews within the Govan Social and Healthcare Integration Partnership (SHIP) project Subscription
Providing pharmacist-led medicines reviews to patients in one of the most deprived areas in Scotland to reduce the health inequality gap.
A locum pharmacist’s decision to substitute one medicine for another may be in the best interest of the patient, but what are the legal and ethical implications?
When her son fell chronically ill, Arlene Brailey found the motivation to take on a role dedicated to helping patients with resistant bacterial infections find support and trustworthy information.
The patient is the only person present at every stage of their treatment as they move between different healthcare settings, meaning that patient-held information could plug holes in our records and contribute to medicines safety.
The pharmacy sector must not underestimate the extent to which the COVID-19 pandemic will transform the NHS.
While news of imminent serology testing is incredibly encouraging, we must be pragmatic about how quickly it can be made available to the general public.
Only 5% of tasks carried out by NHS volunteers so far have been requested by community pharmacies, NHS England has said.
Just over 550 community pharmacy staff members were referred for COVID-19 tests through a national booking system run by the Care Quality Commission, over ten days in mid-April 2020, the NHS watchdog has told The Pharmaceutical Journal.
NHS England has advised pharmacies to risk assess staff who may be particularly vulnerable to COVID-19, including those from a black, Asian or minority ethnic background.
Community pharmacists are to be included in the government life assurance scheme for staff working on the frontline of the COVID-19 pandemic, the health secretary, Matt Hancock has announced.
Community pharmacies need millions of pounds extra “to keep their heads above water” during the COVID-19 pandemic, pharmacy bodies have warned.
Pharmacy staff who are thought to have died as a result of the COVID-19 pandemic are to be among the healthcare workers remembered with a minute’s silence on 28 April 2020.